Fragile X Syndrome: Lessons Learned from the Most Translated Neurodevelopmental Disorder in Clinical Trials

por Duy, Phan Q., Budimirovic, Dejan B.
Publicado 2017

Fragile X Syndrome: Recent Research Updates toward Capturing Treatments’ Improvement in Clinical Trials

por Budimirovic, Dejan B., Protic, Dragana D.
Publicado 2022

Paliperidone and aripiprazole differentially affect the strength of calcium-secretion coupling in female pituitary lactotrophs

por Kucka, Marek, Tomić, Melanija, Bjelobaba, Ivana, Stojilkovic, Stanko S., Budimirovic, Dejan B.
Publicado 2015

Fragile X-Associated Disorders in Serbia: Baseline Quantitative and Qualitative Survey of Knowledge, Attitudes and Practices Among Medical Professionals

por Budimirovic, Dejan B., Cvjetkovic, Smiljana, Bukumiric, Zoran, Duy, Phan Q., Protic, Dragana
Publicado 2018

Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective

por Lee, Anna W., Ventola, Pamela, Budimirovic, Dejan, Berry-Kravis, Elizabeth, Visootsak, Jeannie
Publicado 2018

Genomic studies in fragile X premutation carriers

por Lozano, Reymundo, Hagerman, Randi J, Duyzend, Michael, Budimirovic, Dejan B, Eichler, Evan E, Tassone, Flora
Publicado 2014

Drosophila melanogaster as a Model to Study Fragile X-Associated Disorders

por Trajković, Jelena, Makevic, Vedrana, Pesic, Milica, Pavković-Lučić, Sofija, Milojevic, Sara, Cvjetkovic, Smiljana, Hagerman, Randi, Budimirovic, Dejan B., Protic, Dragana
Publicado 2022

Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment

por Palumbo, Joseph M., Thomas, Brian F., Budimirovic, Dejan, Siegel, Steven, Tassone, Flora, Hagerman, Randi, Faulk, Christopher, O’Quinn, Stephen, Sebree, Terri
Publicado 2023

Fragile X Syndrome: From Molecular Aspect to Clinical Treatment

por Protic, Dragana D., Aishworiya, Ramkumar, Salcedo-Arellano, Maria Jimena, Tang, Si Jie, Milisavljevic, Jelena, Mitrovic, Filip, Hagerman, Randi J., Budimirovic, Dejan B.
Publicado 2022

Profiling early socio-communicative development in five young girls with the preserved speech variant of Rett syndrome

por Marschik, Peter B., Kaufmann, Walter E., Einspieler, Christa, Bartl-Pokorny, Katrin D., Wolin, Thomas, Pini, Giorgio, Budimirovic, Dejan B., Zappella, Michele, Sigafoos, Jeff
Publicado 2012

Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study

por Budimirovic, Dejan B., Dominick, Kelli C., Gabis, Lidia V., Adams, Maxwell, Adera, Mathews, Huang, Linda, Ventola, Pamela, Tartaglia, Nicole R., Berry-Kravis, Elizabeth
Publicado 2021

Peculiarities in the gestural repertoire: An early marker for Rett syndrome?

por Marschik, Peter B., Sigafoos, Jeff, Kaufmann, Walter E., Wolin, Thomas, Talisa, Victor B., Bartl-Pokorny, Katrin D., Budimirovic, Dejan B., Vollmann, Ralf, Einspieler, Christa
Publicado 2012

Updated report on tools to measure outcomes of clinical trials in fragile X syndrome

por Budimirovic, Dejan B., Berry-Kravis, Elizabeth, Erickson, Craig A., Hall, Scott S., Hessl, David, Reiss, Allan L., King, Margaret K., Abbeduto, Leonard, Kaufmann, Walter E.
Publicado 2017

Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis

por Luu, Skylar, Province, Haley, Berry-Kravis, Elizabeth, Hagerman, Randi, Hessl, David, Vaidya, Dhananjay, Lozano, Reymundo, Rosselot, Hilary, Erickson, Craig, Kaufmann, Walter E., Budimirovic, Dejan B.
Publicado 2020

Raising Knowledge and Awareness of Fragile X Syndrome in Serbia, Georgia, and Colombia: A Model for Other Developing Countries?

por Protic, Dragana, Salcedo-Arellano, Maria Jimena, Stojkovic, Maja, Saldarriaga, Wilmar, Ávila Vidal, Laura Alejandra, Miller, Robert M., Tabatadze, Nazi, Peric, Marina, Hagerman, Randi, Budimirovic, Dejan B.
Publicado 2021

Arbaclofen in fragile X syndrome: results of phase 3 trials

por Berry-Kravis, Elizabeth, Hagerman, Randi, Visootsak, Jeannie, Budimirovic, Dejan, Kaufmann, Walter E., Cherubini, Maryann, Zarevics, Peter, Walton-Bowen, Karen, Wang, Paul, Bear, Mark F., Carpenter, Randall L.
Publicado 2017

Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study

por Brašić, James Robert, Nandi, Ayon, Russell, David S., Jennings, Danna, Barret, Olivier, Martin, Samuel D., Slifer, Keith, Sedlak, Thomas, Seibyl, John P., Wong, Dean F., Budimirovic, Dejan B.
Publicado 2021

Best Practices in Fragile X Syndrome Treatment Development

por Erickson, Craig A., Kaufmann, Walter E., Budimirovic, Dejan B., Lachiewicz, Ave, Haas-Givler, Barbara, Miller, Robert M., Weber, Jayne Dixon, Abbeduto, Leonard, Hessl, David, Hagerman, Randi J., Berry-Kravis, Elizabeth
Publicado 2018

A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)

por Berry-Kravis, Elizabeth, Hagerman, Randi, Budimirovic, Dejan, Erickson, Craig, Heussler, Helen, Tartaglia, Nicole, Cohen, Jonathan, Tassone, Flora, Dobbins, Thomas, Merikle, Elizabeth, Sebree, Terri, Tich, Nancy, Palumbo, Joseph M., O’Quinn, Stephen
Publicado 2022

Fragile X targeted pharmacotherapy: lessons learned and future directions

por Erickson, Craig A., Davenport, Matthew H., Schaefer, Tori L., Wink, Logan K., Pedapati, Ernest V., Sweeney, John A., Fitzpatrick, Sarah E., Brown, W. Ted, Budimirovic, Dejan, Hagerman, Randi J., Hessl, David, Kaufmann, Walter E., Berry-Kravis, Elizabeth
Publicado 2017